Director Center for Multiple Myeloma,Massachusetts General Hospital, Associate Professor of Medicine, Harvard Medical School, Boston.
Oncology
Dr. Noopur S. Raje, MD
|
|
Give Review
Noopur S. Raje, MD is an expert in the field of Oncology. She researched medicine at B.J. Medical College - University of Pune. Noopur S. Raje, MD has written publications. She has 39 publications published with PubMed. The lastest publication is: 'Monitoring protein synthesis in single live cancer cells.' She accepts Medicare payments and is listed with Medicare.gov.
Publications
- Ricolinostat (ACY-1215) induced inhibition of aggresome formation accelerates carfilzomib-induced multiple myeloma Cell death.
- Niche-Based Screening in Multiple Myeloma Identifies a Kinesin-5 Inhibitor with Improved Selectivity over Hematopoietic Progenitors.
- Role of Decorin in Multiple Myeloma (MM) Bone Marrow Microenvironment.
- Delineating the mTOR Kinase Pathway Using a Dual TORC1/2 Inhibitor AZD8055 in Multiple Myeloma.
- Biomarkers of Bone Remodeling in Multiple Myeloma Patients to Tailor Bisphosphonate Therapy.
- Outcomes in patients with relapsed or refractory multiple Myeloma in a phase I study of everolimus in combination with lenalidomide.
- Advances in supportive care for multiple Myeloma.
- Preclinical Activity of the Oral Proteasome Inhibitor MLN9708 in Myeloma Bone Disease.
- A novel Bruton's tyrosine kinase inhibitor CC-292 in combination with the proteasome inhibitor carfilzomib impacts the bone microenvironment in a multiple Myeloma mode...
- A phase II trial of lenalidomide, bortezomib and dexamethasone in patients with relapsed and relapsed/refractory Myeloma.
- Pomalidomide alone or in combination with low-dose dexamethasone in relapsed and refractory multiple Myeloma: a randomized phase 2 study.
- Induction of differential apoptotic pathways in multiple myeloma Cells by class-selective histone deacetylase inhibitors.
- Targeting BRAF in Multiple Myeloma.
- Vaccination with Dendritic Cell/Tumor Fusions following Autologous Stem Cell Transplant Induces Immunologic and Clinical Responses in Multiple Myeloma Patients.
- Small-molecule multi-targeted kinase inhibitor RGB-286638 triggers P53-dependent and -independent anti-multiple Myeloma activity through inhibition of transcriptional ...
- Lenalidomide in Combination with an Activin A neutralizing antibody; Preclinical Rationale for a Novel Anti-Myeloma Strategy.
- Tumor promoting immune suppressive Myeloid derived suppressor cells in multiple myeloma microenvironment.
- In vivo and in vitro effects of a novel anti-Dkk1 neutralizing antibody in multiple Myeloma.
- Denosumab, a RANK ligand inhibitor, for the management of bone loss in Cancer patients.
- Clinical trials of bisphosphonates in multiple Myeloma.
- Cyclin dependent kinases in Cancer: Potential for therapeutic intervention.
- Extranodal marginal zone Lymphoma of mucosa-associated lymphoid tissue with amyloid deposition: a clinicopathologic case series.
- Case records of the Massachusetts General Hospital: Case 29-2011: A 66-year-old woman with cardiac and renal failure.
- In vitro and In vivo Selective Antitumor Activity of a Novel Orally Bioavailable Proteasome Inhibitor MLN9708 Against Multiple Myeloma Cells.
- Lenalidomide, bortezomib, pegylated liposomal doxorubicin, and dexamethasone in newly diagnosed multiple Myeloma: a phase 1/2 Multiple Myeloma Research Consortium trial.
- Kidney Disease associated with plasma cell dyscrasias.
- PI3K/p110{delta} is a novel therapeutic target in multiple Myeloma.
- Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple Myeloma.
- Case records of the Massachusetts General Hospital. Case 7-2010. A 49-year-old man with peripheral neuropathy and ascites.
- Interactions of the Hdm2/p53 and proteasome pathways may enhance the antitumor activity of bortezomib.
- The monoclonal antibody nBT062 conjugated to cytotoxic Maytansinoids has selective cytotoxicity against CD138-positive multiple myeloma Cells in vitro and in vivo.
- Biologic sequelae of I{kappa}B kinase (IKK) inhibition in multiple Myeloma: therapeutic implications.
- Preclinical activity of P276-00, a novel small-molecule cyclin-dependent kinase inhibitor in the therapy of multiple Myeloma.
- SNX-2112, a selective Hsp90 inhibitor, potently inhibits tumor Cell growth, angiogenesis, and osteoclastogenesis in multiple myeloma and other hematologic tumors by ab...
- Lenalidomide inhibits osteoclastogenesis, survival factors and bone-remodeling markers in multiple Myeloma.
- Case records of the Massachusetts General Hospital. Case 9-2008. A 65-year-old woman with a nonhealing ulcer of the jaw.
- MicroRNA expression patterns in medullary and extramedullary plasmacytoma.
- Monitoring protein synthesis in single live Cancer cells.
Procedures Preformed
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anemia
- Bladder Cancer
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
Brigham and Women's Hospital -
Massachusetts General Hospital -
B.J. Medical College - University of Pune
Hospital
-
Massachusetts General Hospital
Drug Facts
| NPI NUMBER | 1013991504 | |
| NPPES Provider LastName | RAJE | |
| NPPES Provider FirstName | NOOPUR | |
| NPPES Provider ZIPCode | 021142621 | |
| NPPES Provider State | MA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 233.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1013991504 |
| Last Name Of The Provider | RAJE |
| First Name Of The Provider | NOOPUR |
| View All |
Similar Doctors
|
|
Dr. Mary L. Peters, MD |
|
|
Dr. Michaela J. Higgins, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Mandar D. Muzumdar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hao Zhu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wendy S. Garrett, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Douglas E. Brandoff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sridhar Ramaswamy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aymen Elfiky, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Benjamin B. Freeman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David W. Allen, MD |